anthrax vaccine adsorbed (AVA)
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:administered_by |
injection
|
| gptkbp:administration_schedule |
0, 7, and 21 or 28 days
|
| gptkbp:antigen |
protective antigen
|
| gptkbp:approves |
gptkb:1970
gptkb:U._S._Food_and_Drug_Administration |
| gptkbp:associated_with |
gptkb:Bacillus_anthracis
|
| gptkbp:booster_required |
every 1 to 3 years
|
| gptkbp:clinical_trial |
conducted for safety and efficacy
high-risk occupations |
| gptkbp:contraindication |
severe allergic reactions
|
| gptkbp:developed_by |
gptkb:U._S._Army_Medical_Research_Institute_of_Infectious_Diseases
|
| gptkbp:dosage_form |
3 doses
|
| gptkbp:duration_of_immunity |
approximately 2 years
|
| https://www.w3.org/2000/01/rdf-schema#label |
anthrax vaccine adsorbed (AVA)
|
| gptkbp:is_recommended_for |
gptkb:military_personnel
laboratory workers |
| gptkbp:is_vulnerable_to |
varies by provider
intramuscular subunit vaccine supported by government and private sectors high in healthy adults based on clinical trials available through select healthcare providers based on research from the 1950s continues for improved formulations developed in response to anthrax outbreaks limited to specific populations lower in immunocompromised individuals significant in preventing anthrax outbreaks |
| gptkbp:manufacturer |
gptkb:Emergent_Bio_Solutions
|
| gptkbp:notable_for |
bioterrorism preparedness
|
| gptkbp:post_exposure_prophylaxis |
not recommended
|
| gptkbp:safety_measures |
ongoing post-marketing surveillance
|
| gptkbp:serological_response |
measured by antibody levels
|
| gptkbp:side_effect |
fatigue
headache muscle pain nausea fever local reactions systemic reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:targets |
gptkb:disease
|
| gptkbp:type |
inactivated vaccine
|
| gptkbp:used_for |
prevention of anthrax
|
| gptkbp:vaccine_labeling |
includes contraindications and warnings
|
| gptkbp:vaccine_regulation |
regulated by the FDA
|
| gptkbp:bfsParent |
gptkb:inhalation_anthrax
|
| gptkbp:bfsLayer |
5
|